Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Invested Capital (2016 - 2025)

Marimed (MRMD) has disclosed Invested Capital for 15 consecutive years, with $54.1 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 13.5% to $54.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.1 million through Dec 2025, down 13.5% year-over-year, with the annual reading at $54.1 million for FY2025, 13.5% down from the prior year.
  • Invested Capital for Q4 2025 was $54.1 million at Marimed, down from $58.7 million in the prior quarter.
  • The five-year high for Invested Capital was $113.0 million in Q2 2023, with the low at $14.8 million in Q1 2021.
  • Average Invested Capital over 5 years is $61.1 million, with a median of $60.2 million recorded in 2022.
  • The sharpest move saw Invested Capital skyrocketed 20139.53% in 2021, then tumbled 36.69% in 2024.
  • Over 5 years, Invested Capital stood at $36.3 million in 2021, then surged by 64.57% to $59.8 million in 2022, then rose by 20.76% to $72.2 million in 2023, then fell by 13.49% to $62.5 million in 2024, then fell by 13.5% to $54.1 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $54.1 million, $58.7 million, and $60.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.